Companies / Vilex

Vilex coverage

5 issues

• Is Transverse Tibial Transport the Next Gold Rush?

  Six companies already have systems. The evidence is promising but unfinished, the wound indication isn't on the label, and scope of practice may decide who gets to use it. Plus HyperFlex walks into the lion's den, and every AOFAS 2026 industry lab in one place.

• AOFAS Savannah Preview: MIS Achilles and the New Launches

  Unsolicited advice for exhibitors and surgeons, plus a challenger to Arthrex PARS.

• No Summer Break: Paragon 28, Enovis, Ossio, and Vilex Launch

  Four launches heading into AOFAS, plus a read on the May 510(k) clearances.

• ConMed Acquires In2Bones — Who's Next to Go?

  The details of the deal, plus Q1 earnings from Treace and Paragon 28.

• Total Ankle Shake-Up: The STAR Lands at DJO

  Regulators force a divestiture, Vilex takes Hintegra, and APEX 3D clears the FDA.